'For
the quarter ending March 2024, consolidated Net sales (including other operating income) of Dr Lal Pathlabs has increased 11.08% to Rs 545.4 crore compared to quarter ended March 2023. Operating profit margin has jumped from 23.54% to 26.53%, leading to 25.17% rise in operating profit to Rs 144.70 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 21.57% to 19.97%. Employee cost increased from 18.84% to 19.33%. Other expenses fell from 36.05% to 34.18%. Selling and administration expenses fell from 14.01% to 13.86%. Other income rose 29.58% to Rs 18.4 crore. PBIDT rose 25.65% to Rs 163.1 crore. Provision for interest fell 26.67% to Rs 6.6 crore. Loan funds declined from Rs 419.50 crore as of 31 March 2023 to Rs 246.90 crore as of 31 March 2024. Inventories rose to Rs 37.30 crore as of 31 March 2024 from Rs 33.80 cror...
Pleaselogin & subscribe to view the full report.
More Reports
|
|